Caring Brands, Inc. CABR

Healthcare SIC 2844 - Perfumes, Cosmetics & Other Toilet Preparations NAICS Manufacturing › Chemical Manufacturing › Soap, Cleaning Compound, and Toilet Preparation Manufacturing derived Nasdaq

are a wellness consumer products company. We offer several over-the-counter (OTC) and cosmetic consumer products. Our product pipeline

includes a diverse range of products, such as hair loss treatments, eczema and psoriasis treatments, vitiligo solutions, a jellyfish

sting protective suncare line, and women's sexual wellness products, catering to diverse health and wellness needs. Our method

of operation ensures that (1) the mechanism of action of all products is established, (2) efficacy is determined through controlled clinical

Last close 1.05 2026-10-23
Market cap $10.9M 2026-06-30 share count
52-week range 0.71 - 3.20

Valuation FY2025 figures against the last close

P/S2,582.8x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-0.46

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023
Revenue $4.2K——
Cost of revenue $1.9K——
Gross profit $2.3K——
R&D $0$39.6K—
SG&A $147.7K——
Total operating expenses $5.9M——
Operating income -$5.9M——
Interest expense $19.2K——
Pre-tax income -$6.3M-$1.5M—
Income tax $0$0—
Net income -$6.3M-$1.5M—
EPS, basic -0.46——
EPS, diluted -0.46——
Shares, diluted (wtd. avg.) 13.6M——

Balance sheet

Fiscal year FY2025FY2024FY2023
Cash and equivalents $2.2M$469.0K—
Inventory $12.8K$13.7K—
Total current assets $2.3M$527.5K—
Other intangibles $2.5M$2.9M—
Total assets $2.3M$3.9M—
Accounts payable $170.4K$169.4K—
Total current liabilities $176.8K$186.1K—
Long-term debt $58.6K——
Total liabilities $235.5K$186.1K—
Retained earnings -$7.1M-$862.8K—
Total equity $2.1M-$920.4K-$265.8K

Cash flow

Fiscal year FY2025FY2024FY2023
Operating cash flow -$1.7M——
Stock-based compensation $1.2M——
Financing cash flow $3.4M——

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-021346.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -8M -6M -4M -2M 0 2M Net income, FY2024: -1.5M Revenue, FY2025: 4.2K Gross profit, FY2025: 2.3K Net income, FY2025: -6.3M FY2023 FY2024 FY2025
Fiscal year FY2023FY2024FY2025
Revenue — — $4.2K
Gross profit — — $2.3K
Net income — -$1.5M -$6.3M

Recent filings and events

  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Unregistered share sale Item 3.02
  • Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
  • Other event Item 8.01
  • Delisting notice The exchange has told the company it no longer meets the rules for staying listed - usually price, market cap, or filings that are late. Item 3.01
  • Material agreement signed Item 1.01
  • Unregistered share sale Item 3.02
  • Shareholder rights changed The terms attaching to the shares themselves have changed. Item 3.03
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2844

TickerCompanyMarket capP/ERevenue growth
CL COLGATE PALMOLIVE CO $74.97B 35.8x 1.4%
EL ESTEE LAUDER COMPANIES INC $39.37B 217.3x 5.0%
KVUE Kenvue Inc. $37.59B 25.8x -2.1%
ELF e.l.f. Beauty, Inc. $6.74B 259.6x 24.6%
IPAR INTERPARFUMS INC $3.69B 22.0x 2.5%
COTY COTY INC. $2.84B — -1.5%
EPC EDGEWELL PERSONAL CARE Co $1.29B 52.9x -1.3%
WALD Waldencast plc $100.3M — -0.7%